NEW WAYS TO EXTEND THE STORAGE PERIOD OF ERYTHROCYTE CONTENT COMPONENTS THROUGH NANOTECHNOLOGY

In this work for the first time, in comparing with controls, the indicators that characterize dependence of hemolysis terms appearance on multiplicity of blood processing with nanoparticles MCS-B. It was found that extracorporeal blood treatment with MCS-B nanoparticles significantly reduces the activity of Ca, Mg-ATPase of erythrocytes. The performed researches confirm that with the help of nanoparticles of the MCS-B, it is possible not only to significantly reduce hemolysis, thereby extending the shelf life of the blood, but also to affect the activity of adenosine trisphosphatase of erythrocytes, to regulate the transmembrane exchange, and to affect extracorporarily the cellular apoptosis.